X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (59) 59
humans (53) 53
fostamatinib disodium (52) 52
protein-tyrosine kinases - antagonists & inhibitors (23) 23
fostamatinib (22) 22
hematology (22) 22
oncology (22) 22
syk (22) 22
chronic lymphocytic-leukemia (20) 20
animals (19) 19
non-hodgkin-lymphoma (18) 18
chronic lymphocytic leukemia (17) 17
spleen tyrosine kinase (17) 17
syk kinase (17) 17
leukemia, lymphocytic, chronic, b-cell - drug therapy (16) 16
receptors, antigen, b-cell - metabolism (16) 16
signal transduction (16) 16
activation (15) 15
leukemia, lymphocytic, chronic, b-cell - metabolism (14) 14
protein kinase inhibitors - therapeutic use (14) 14
protein-tyrosine kinases - metabolism (14) 14
tyrosine kinase inhibitor (14) 14
hemic and lymphatic diseases (13) 13
ibrutinib (13) 13
mice (13) 13
rheumatoid-arthritis (13) 13
signal transduction - drug effects (13) 13
female (12) 12
protein kinase inhibitors - pharmacology (12) 12
syk inhibitor (12) 12
therapeutic target (12) 12
antineoplastic agents - therapeutic use (11) 11
intracellular signaling peptides and proteins - antagonists & inhibitors (11) 11
leukemia, lymphocytic, chronic, b-cell - pathology (11) 11
lymphomas (11) 11
male (11) 11
b-cell receptor (10) 10
middle aged (10) 10
pharmacology & pharmacy (10) 10
tyrosine (10) 10
health aspects (9) 9
oxazines - therapeutic use (9) 9
pyridines - therapeutic use (9) 9
aged (8) 8
antineoplastic agents - pharmacology (8) 8
article (8) 8
cell line, tumor (8) 8
cll (8) 8
expression (8) 8
in-vitro (8) 8
leukemia, lymphocytic, chronic, b-cell - genetics (8) 8
medicine & public health (8) 8
analysis (7) 7
apoptosis (7) 7
b-cell-receptor (7) 7
b-cells (7) 7
care and treatment (7) 7
clinical trials (7) 7
double-blind (7) 7
drug therapy (7) 7
intracellular signaling peptides and proteins - metabolism (7) 7
lymphoma (7) 7
microenvironment (7) 7
pci-32765 (7) 7
pharmacokinetics (7) 7
pyrimidines - pharmacology (7) 7
rheumatoid arthritis (7) 7
survival (7) 7
adult (6) 6
cancer (6) 6
idelalisib (6) 6
immunology (6) 6
inflammation (6) 6
molecular targeted therapy (6) 6
nf-kappa-b (6) 6
open-label (6) 6
oxazines - pharmacology (6) 6
phase-ii (6) 6
pyridines - pharmacology (6) 6
research (6) 6
rituximab (6) 6
syk kinase - antagonists & inhibitors (6) 6
syk kinase - metabolism (6) 6
t-cells (6) 6
tyrosine kinase (6) 6
abridged index medicus (5) 5
aged, 80 and over (5) 5
antigen receptor (5) 5
antigen-receptor (5) 5
arthritis, rheumatoid - drug therapy (5) 5
brutons tyrosine kinase (5) 5
btk (5) 5
cell proliferation - drug effects (5) 5
cells, cultured (5) 5
chemistry, medicinal (5) 5
in-vivo (5) 5
initial therapy (5) 5
kinases (5) 5
leukemia (5) 5
leukemia, lymphocytic, chronic, b-cell - immunology (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
BLOOD, ISSN 0006-4971, 03/2015, Volume 125, Issue 10, pp. 1578 - 1588
Chronic lymphocytic leukemia (CLL) is a common B-cell malignancy characterized by a highly variable course and outcome. The disease is believed to be driven by... 
B-CELL RECEPTOR | SIGNALING PATHWAYS | HEAVY-CHAIN IIA | TYROSINE KINASE | APOPTOTIC CELLS | FOSTAMATINIB DISODIUM | CHRONIC LYMPHOCYTIC-LEUKEMIA | CD38 EXPRESSION | HEMATOLOGY | GENE MUTATION STATUS | DISEASE PROGRESSION
Journal Article
Journal Article
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, ISSN 1520-4391, 12/2012, pp. 88 - 96
Chronic lymphocytic leukemia (CLL) is a malignancy of mature B cells that depend on host factors in the tissue microenvironment for survival and proliferation.... 
SURVIVAL | BCR | ACTIVATION | B-CELL-RECEPTOR | TYROSINE KINASE | FOSTAMATINIB DISODIUM | NON-HODGKIN-LYMPHOMA | HEMATOLOGY | AUTOIMMUNE-DISEASE | SYK INHIBITOR | EDUCATION, SCIENTIFIC DISCIPLINES | ANTIGEN
Journal Article
International Journal of Clinical Rheumatology, ISSN 1758-4272, 02/2010, Volume 5, Issue 1, pp. 9 - 15
Journal Article
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 67, pp. 111495 - 111507
B cell lymphoma (BCL) is the most frequently diagnosed type of non-Hodgkin lymphoma (NHL), and accounts for about 4% of all cancers in the USA. Kinases spleen... 
SKLB-850 | B cell lymphoma | Multikinase inhibitor | ACTIVATION | SYK | CELL BIOLOGY | IN-VITRO | RITUXIMAB | FOSTAMATINIB DISODIUM | RESISTANCE | CHRONIC LYMPHOCYTIC-LEUKEMIA | TYROSINE KINASE INHIBITOR | NON-HODGKIN-LYMPHOMA | multikinase inhibitor | TUMOR-GROWTH
Journal Article